SCHEMBL7902073

SCHEMBL7902073

CCCCCCCCCCCCCCCCCCNC(=Nc1ccncc1)NC#N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.48
HRH4 Q9H3N8 8/20 0.43
HRH3 Q9Y5N1 1/20 0.41
QPCT Q16769 1/20 0.41
IMPDH2 P12268 1/20 0.37
CYP3A4 P08684 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX15 P16050 1/20 0.37
NFKB1 P19838 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
HIF1A Q16665 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MAPT P10636 1/20 0.37
ABCC9 O60706 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
GLA P06280 1/20 0.37
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7900339 1.00 NAAA (0.48) NAAAHRH4HRH3QPCTIMPDH2
SCHEMBL7898979 1.00 NAAA (0.48) NAAAHRH4HRH3QPCTIMPDH2
SCHEMBL7098788 0.88 HRH4 (0.43) NAAAHRH4HRH3QPCTCYP3A4
SCHEMBL7677658 0.87 HRH4 (0.43) HRH4HRH3QPCTCYP3A4CYP1A2
SCHEMBL7262252 0.87 ACHE (0.44) NAAAMGLL
SCHEMBL7592127 0.87 ACHE (0.44) NAAAMGLL
SCHEMBL7892936 0.85 HPGD (0.45) NAAAHRH4HRH3IMPDH2CYP3A4
SCHEMBL11166909 0.85 HPGD (0.45) NAAAHRH4HRH3IMPDH2CYP3A4
SCHEMBL7262289 0.84 CYP1A2 (0.53) NAAAHRH4HRH3QPCTCYP1A2
SCHEMBL11160670 0.84 HPGD (0.46) HRH4HRH3QPCTCYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6197797-B1 ANTICANCER AGENTS; SKIN DISORDERS Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 2001-03-06 US disclosed